
The 10 Most Innovative Life Sciences Deals Of 2017
These transactions best exemplify the most significant trends in the life sciences and biotech space.
These transactions best exemplify the most significant trends in the life sciences and biotech space.
Leaders of WilmerHale’s life sciences practice share trends they see regarding acquisitions and initial public offerings.
The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want.
Still recovering from a market correction two years ago, and with a scarcity of attractive targets and ongoing macroeconomic uncertainty, the life sciences dealmaking space is in a state of flux.
After a relatively slow 2016 for life sciences deals...
Last year proved a slow one for dealmaking in the life sciences space. But that didn’t stop two of the major legal players in it from consummating one themselves: In November, Arnold & Porter and Kaye Scholer agreed to merge, bringing together two formidable healthcare practices.
One year ago, in collaboration with Lake Whillans and our sister site MedCity News, we launched the inaugural Life Sciences Law Firm Index to recognize law firms that are the most active and relevant for life science companies. Over the course of 2016, we have published updates to the Index, each focusing on a different practice area. Today, […]
In January 2016, in collaboration with Lake Whillans and our sister site Above the Law, we published the inaugural Life Sciences Law Firm Index to help identify which law firms are the most active and relevant for life science companies. The goal of the Index is to inform innovators about which firms are the leaders in the […]